| Identification | Back Directory | [Name]
2-{[(5-bromo-2-thienyl)methylene]amino}benzamide | [CAS]
304456-62-0 | [Synonyms]
MDK6620
INVIVO6620
BTYNB IMP1 Inhibitor
BTYNB，BTYNB IMP1 Inhibitor
2-{[(5-bromo-2-thienyl)methylene]amino}benzamide
Benzamide, 2-[[(5-bromo-2-thienyl)methylene]amino]-
2-(((5-Bromothiophen-2-yl)methylene)amino)benzamide | [Molecular Formula]
C12H9BrN2OS | [MDL Number]
MFCD00977636 | [MOL File]
304456-62-0.mol | [Molecular Weight]
309.18 |
| Hazard Information | Back Directory | [Description]
MDK6620, also known as BTYNB IMP1 Inhibitor. is an inhibitor of the oncofetal mRNA-binding protein IMP1 (IC50 = 5 μM for IMP1 binding to c-Myc mRNA). | [Uses]
BTYNB is a potent and selective inhibitor of IMP1 binding to c-Myc mRNA (IC50=5 μM). BTYNB exhibits selectivity and effectiveness against IMP1-postive cancer cell lines. BTYNB can be used for cancer research[1]. | [storage]
4°C, protect from light | [References]
[1] Lily Mahapatra,et al. A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation. Transl Oncol DOI:10.1016/j.tranon.2017.07.008 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|